ES3058528T3 - Process for producing a tablet comprising glp-1 peptides - Google Patents

Process for producing a tablet comprising glp-1 peptides

Info

Publication number
ES3058528T3
ES3058528T3 ES20764666T ES20764666T ES3058528T3 ES 3058528 T3 ES3058528 T3 ES 3058528T3 ES 20764666 T ES20764666 T ES 20764666T ES 20764666 T ES20764666 T ES 20764666T ES 3058528 T3 ES3058528 T3 ES 3058528T3
Authority
ES
Spain
Prior art keywords
glp
peptides
tablet
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20764666T
Other languages
English (en)
Spanish (es)
Inventor
Pall Ingvarsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES3058528T3 publication Critical patent/ES3058528T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES20764666T 2019-09-02 2020-09-02 Process for producing a tablet comprising glp-1 peptides Active ES3058528T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19194868 2019-09-02
PCT/EP2020/074426 WO2021043803A1 (en) 2019-09-02 2020-09-02 Process for producing a tablet comprising glp-1 peptides

Publications (1)

Publication Number Publication Date
ES3058528T3 true ES3058528T3 (en) 2026-03-11

Family

ID=67840964

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20764666T Active ES3058528T3 (en) 2019-09-02 2020-09-02 Process for producing a tablet comprising glp-1 peptides

Country Status (10)

Country Link
US (1) US20220409701A1 (sr)
EP (1) EP4025192B1 (sr)
JP (1) JP7767264B2 (sr)
CN (1) CN114340655A (sr)
BR (1) BR112022002189A2 (sr)
ES (1) ES3058528T3 (sr)
HR (1) HRP20251672T1 (sr)
IL (1) IL290056A (sr)
RS (1) RS67632B1 (sr)
WO (1) WO2021043803A1 (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201800492T1 (it) 2013-05-02 2018-11-09 Novo Nordisk As Dosaggio orale di composti di glp-1
MX2024000768A (es) * 2021-07-15 2024-02-12 Novo Nordisk As Comprimido que comprende una sal del acido n-(8-(2-hidroxibenzoil) amino)caprilico.
CN114984191B (zh) * 2022-07-04 2022-10-25 北京惠之衡生物科技有限公司 一种多肽类药物口服递送组合物
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
WO2025133729A1 (en) 2023-12-18 2025-06-26 Assia Chemical Industries Ltd. Process for preparation of glp-1 peptides and dual glp-1/gip peptides having controlled particle size
CN118319871B (zh) * 2024-04-19 2025-08-05 鲁南新时代生物技术有限公司 一种司美格鲁肽药物组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
EP2164466A1 (en) 2007-06-01 2010-03-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
CN102123697B (zh) 2008-08-18 2015-06-10 安特拉贝欧有限公司 用于口服给予蛋白质的方法和组合物
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
MX345501B (es) * 2010-12-16 2017-02-02 Novo Nordisk As Composiciones solidas que comprenden agonista de glp-1 y sal del acido n-(8-(2-hidroxibenzoil)amino)caprilico.
KR101972836B1 (ko) 2011-04-12 2019-04-29 노보 노르디스크 에이/에스 이중 아실화된 ｇｌｐ-1 유도체
WO2013139695A1 (en) 2012-03-22 2013-09-26 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
EP2827885B1 (en) * 2012-03-22 2018-08-15 Novo Nordisk A/S Compositions of glp-1 peptides and preparation thereof
US9993430B2 (en) * 2012-06-20 2018-06-12 Novo Nordisk A/S Tablet formulation comprising semaglutide and a delivery agent
ES2741507T3 (es) * 2014-04-07 2020-02-11 Novo Nordisk As Compuestos de glp-1 acilados doblemente
EP4299118A3 (en) 2018-02-02 2024-04-10 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant

Also Published As

Publication number Publication date
BR112022002189A2 (pt) 2022-04-26
JP7767264B2 (ja) 2025-11-11
EP4025192C0 (en) 2025-12-03
CN114340655A (zh) 2022-04-12
WO2021043803A1 (en) 2021-03-11
US20220409701A1 (en) 2022-12-29
RS67632B1 (sr) 2026-02-27
EP4025192B1 (en) 2025-12-03
JP2022545862A (ja) 2022-11-01
IL290056A (en) 2022-03-01
HRP20251672T1 (hr) 2026-02-13
EP4025192A1 (en) 2022-07-13

Similar Documents

Publication Publication Date Title
ES3058528T3 (en) Process for producing a tablet comprising glp-1 peptides
SG11202107123TA (en) Process for preparing a gip/glp1 dual agonist
GB2585450B (en) Tablet production
SI3812371T1 (sl) Postopek za pripravo brivaracetama
IL285858A (en) A process for making levoamphetamine
PL3772996T3 (pl) Sposób wytwarzania tabletki bulionowej
GB201815390D0 (en) A process for producing a bio-based surfactant
PL3773000T3 (pl) Sposób wytwarzania tabletki bulionowej
EP3844068B8 (en) Apparatus for producing a structure in space
GB2583719B (en) Recycling process
ZA202108298B (en) Process for producing highly activated electrode through electro-activation
IL285391A (en) A process for spray-drying a glp-1 peptide
GB201916577D0 (en) Process for forming a fuel pellet
PL3802529T3 (pl) Sposób wytwarzania palbocyklibu
PL3741744T3 (pl) Farmaceutyczny produkt pośredni do wytwarzania pimawanseryny
HUE063773T2 (hu) Oxigéninjektáló rendszer direkt redukciós eljáráshoz
PL4004165T3 (pl) Sposób wykonania tabletki paliwowej
PL3773015T3 (pl) Sposób wytwarzania tabletki bulionowej
IL286006A (en) Process for preparing 4-amino-5-methylpyridone
PT3742907T (pt) Processo para preparar uma tablete de caldo
SI3459531T1 (sl) Postopek za proizvodnjo slojevite tablete
PL4017289T3 (pl) Sposób wytwarzania tabletki bulionowej
SG11202107656TA (en) Abc transporters for the high efficiency production of rebaudiosides
HK40035608A (en) A process for preparing a glucagon-like peptide
GB2578367B (en) Process for preparing a metal-organic framework